Status:
RECRUITING
Effect of Abdominal Wall Injections on Abdominal Pain
Lead Sponsor:
Oregon Health and Science University
Conditions:
Anterior Cutaneous Nerve Entrapment Syndrome
Eligibility:
All Genders
18-100 years
Phase:
PHASE4
Brief Summary
This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at...
Detailed Description
This is a prospective cohort study of outpatient adults with chronic abdominal wall pain who receive abdominal wall injections with lidocaine at an academic medical center. Thirty patients will be enr...
Eligibility Criteria
Inclusion
- Localized abdominal wall pain
- Average daily pain (7-day recall) ≥ 3 on a scale of 0-10
- Suspected abdominal wall etiology for abdominal pain
- Positive Carnett's sign or pain near an incisional site
- 18 years of age or older
Exclusion
- Suspected visceral etiology for the abdominal pain
- Severe allergy to lidocaine
- Unwillingness or inability to provide informed consent
- Low probability of follow-up
- Abdominal wall hernia noted at the point of pain
- History of trigger point injections for abdominal pain
- Bleeding disorder
- Pregnancy, incarceration or decisionally impaired
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06121466
Start Date
January 1 2023
End Date
December 1 2025
Last Update
September 2 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
OHSU
Portland, Oregon, United States, 97239
2
Oregon Health Sciences University
Portland, Oregon, United States, 97239